AI vs. an analyst: Seven predictions about the future of the insight business
The arrival of artificial intelligence generally, and ChatGPT specifically, has generated a massive amount of discussion about both opportunities and potential threats.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
-
Working with AI is like working with an early-career research…
- ChatGPT vs. human analyst?
- ChatGPT is the hands-down, no-question winner at speed in synthesizing…
- ChatGPT also wins on speaking specialized language from Day One.
- Where ChatGPT would tie against a weak analyst—but not a…
- What ChatGPT cannot do, that a strong analyst can do:…
- ChatGPT only knows things people will say “in public” and…
- ChatGPT can’t do off-the-record primary research.
- ChatGPT won’t give me feedback on my questions.
- ChatGPT vs. human analyst?
-
7 takeaways about what all this means for the healthcare…
The arrival of artificial intelligence generally, and ChatGPT specifically, has generated a massive amount of discussion about both opportunities and potential threats. Within healthcare, the ChatGPT discussion has primarily focused on patient- and clinician-facing applications, with aims such as achieving scale in primary care, reducing the burden of clinical documentation, and facilitating clinical research.
Less has been written about the business side of healthcare, where presumably ChatGPT could be no less of an essential tool, as well as causing new problems. For a research/knowledge/insights-driven business such as Union, the opportunity would clearly be to drastically improve efficiency in the research process. The worries range from the immediate (what quality of the information does this tool generate?) to the existential (is human expert-led research about to be drowned out by a flood of AI-generated content?)
To gain some first-hand experience, I spent time putting the tool through its paces, quizzing it about healthcare strategy research-type topics such as the role of private equity in healthcare, Medicare program mechanics, players in the life science industry, the pharmacy value chain, and some hard-to-find info about provider contract rates—topics that overlapped with live projects I am currently working on.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
Healthcare’s next forced efficiency leap is AI. Where does your organization stand?
The health-system utilization forecasting conundrum: One size definitely doesn’t fit all.
Key takeaways from our Chicago Revenue Cycle Summit